Synthesis of novel polymeric nanoparticles (methoxy-polyethylene glycol-chitosan/hyaluronic acid) containing 7-ethyl-10-hydroxycamptothecin for colon cancer therapy: in vitro, ex vivo and in vivo investigation

References

• Khalek FJA, Gallicano GI, Mishra L. Colon cancer stem cells. Gastrointest Cancer Res. 2010;(Suppl 1):S16.
   PubMedGoogle Scholar
• Ebrahimnejad P, Dinarvand R, Jafari MR, et al. Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38. Int J Pharm. 2011;406(1-2):122–127.
   PubMed Web of Science ®Google Scholar
• Mohammady H, Dinarvand R, Esfandyari MM, et al. Encapsulation of irinotecan in polymeric nanoparticles: characterization, release kinetic and cytotoxicity evaluation. Nanomed J. 2016;3(3):159–168.
   Google Scholar
• Ebrahimnejad P, Dinarvand R, Sajadi S, et al. Preparation and characterization of poly lactide-co-glycolide nanoparticles of SN-38. PDA J Pharm Sci Technol. 2009;63(6):512–520.
   PubMedGoogle Scholar
• Guo M, Rong W-T, Hou J, et al. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Nanotechnology. 2013;24(24):245101–245120.
   PubMed Web of Science ®Google Scholar
• Ebrahimnejad P, Dinarvand R, Sajadi A, et al. Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell lines. Nanomedicine. 2010;6(3):478–485.
   PubMed Web of Science ®Google Scholar
• Ramezani P, Abnous K, Taghdisi SM, et al. Targeted MMP-2 responsive chimeric polymersomes for therapy against colorectal cancer. Colloids Surf B Biointerfaces. 2020;193:111135.
   PubMed Web of Science ®Google Scholar
• Ebrahimnejad P, Jafari M, Heidari D. An efficient method for fabrication of carboxylated short multi-walled carbon nanotubes decorated with magnetic iron oxide nanoparticles. Curr Nanosci. 2013;9(5):615–618.
   Web of Science ®Google Scholar
• Dinarvand M, Kiani M, Mirzazadeh F, et al. Oral delivery of nanoparticles containing anticancer SN38 and hSET1 antisense for dual therapy of colon cancer. Int J Biol Macromol. 2015;78:112–121.
   PubMed Web of Science ®Google Scholar
• Alkhader E, Roberts CJ, Rosli R, et al. Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles. J Biomater Sci Polym Ed. 2018;29(18):2281–2298.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang Y, Xu J, et al. Reversing tumor stemness via orally targeted nanoparticles achieves efficient colon cancer treatment. Biomaterials. 2019;216:119247.
   PubMed Web of Science ®Google Scholar
• Roger E, Lagarce F, Benoit J-P. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration. Eur J Pharm Biopharm. 2011;79(1):181–188.
   PubMed Web of Science ®Google Scholar
• Prasad S, Dangi J. Development and characterization of pH responsive polymeric nanoparticles of SN-38 for colon cancer. Artif Cells Nanomed Biotechnol. 2016;44(8):1824–1834.
   PubMed Web of Science ®Google Scholar
• Bala V, Rao S, Li P, et al. Lipophilic prodrugs of SN38: synthesis and in vitro characterization toward oral chemotherapy. Mol Pharmaceutics. 2016;13(1):287–294.
   PubMed Web of Science ®Google Scholar
• Mir M, Ebrahimnejad P. Preparation and characterization of bifunctional nanoparticles of vitamin E TPGS-emulsified PLGA-PEG-FOL containing deferasirox. J Nanosci Nanotechnol. 2015;4(2):80–87.
   Google Scholar
• Lin PY, Chiu YL, Huang JH, et al. Oral nonviral gene delivery for chronic protein replacement therapy. Adv Sci. 2018;5(8):1701079.
   Web of Science ®Google Scholar
• Almalik A, Donno R, Cadman CJ, et al. Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation. J Control Release. 2013;172(3):1142–1150.
   PubMed Web of Science ®Google Scholar
• Xia P, Xu X-Y. Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses. Oncotarget. 2016;7(29):45538–45546.
   PubMedGoogle Scholar
• Sadeghi Ghadi Z, Ebrahimnejad P. Curcumin entrapped hyaluronan containing niosomes: preparation, characterization and in vitro/in vivo evaluation . J Microencapsul. 2019;36(2):169–179.
   PubMed Web of Science ®Google Scholar
• Sadeghi-Ghadi Z, Vaezi A, Ahangarkani F, et al. Potent in vitro activity of curcumin and quercetin co-encapsulated in nanovesicles without hyaluronan against Aspergillus and Candida isolates. J Mycol Med. 2020;30(4):101014.
   PubMed Web of Science ®Google Scholar
• Ghadi ZS, Dinarvand R, Asemi N, et al. Preparation, characterization and in vivo evaluation of novel hyaluronan containing niosomes tailored by Box-Behnken design to co-encapsulate curcumin and quercetin. Eur J Pharm Sci. 2019;130(2):234–246.
   PubMed Web of Science ®Google Scholar
• Hsieh C-M, Huang Y-W, Sheu M-T, et al. Biodistribution profiling of the chemical modified hyaluronic acid derivatives used for oral delivery system. Int J Biol Macromol. 2014;64:45–52.
   PubMed Web of Science ®Google Scholar
• de Souza AB, Chaud MV, Santana MHA. Hyaluronic acid behavior in oral administration and perspectives for nanotechnology-based formulations: a review. Carbohydr Polym. 2019;222:115001.
   PubMed Web of Science ®Google Scholar
• Pereira LA, da Silva Reis L, Batista FA, et al. Biological properties of chitosan derivatives associated with the ceftazidime drug. Carbohydr Polym. 2019;222:115002.
   PubMed Web of Science ®Google Scholar
• Khalili S, Ebrahimnezhad P. Survival of Lactobacillus Acidophilus as probiotic bacteria using chitosan nanoparticles. Int J Eng. 2017;30(4):456–463.
   Google Scholar
• Khan Z, Pillay V, Choonara YE, et al. Drug delivery technologies for chronotherapeutic applications. Pharm Dev Technol. 2009;14(6):602–612.
   PubMed Web of Science ®Google Scholar
• Duceppe N, Tabrizian M. Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles. Biomaterials. 2009;30(13):2625–2631.
   PubMed Web of Science ®Google Scholar
• Jafari M, Heidari D, Ebrahimnejad P. Synthesizing and characterizing functionalized short multiwall carbon nanotubes with folate, magnetite and polyethylene glycol as multi-targeted nanocarrier of anti-cancer drugs. Iran J Pharm Res. 2016;15(2):449–456.
   PubMed Web of Science ®Google Scholar
• Chung-Wook C, Kyu-Don C, Young-Il J, et al. 5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy. Int J Nanomedicine. 2013;8(1):809–819.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang H, Wu Z, et al. Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles. Eur J Pharm Biopharm. 2008;68(3):526–534.
   PubMed Web of Science ®Google Scholar
• Taghavi S, Abnous K, Babaei M, et al. Synthesis of chimeric polymersomes based on PLA-b-PHPMA and PCL-b-PHPMA for nucleoline guided delivery of SN38. Nanomed Nanotechnol Biol Med. 2020; 28:102227.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Amel Farzad S, Mohammadi M, et al. Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38. Artif Cells Nanomed Biotechnol. 2018;46(sup2):1003–1014.
   PubMed Web of Science ®Google Scholar
• Taleghani AS, Ebrahimnejad P, Heidarinasab A, et al. Sugar-conjugated dendritic mesoporous silica nanoparticles as pH-responsive nanocarriers for tumor targeting and controlled release of deferasirox. Mater Sci Eng C Mater Biol Appl. 2019;98(85):358–368.
   PubMed Web of Science ®Google Scholar
• Kulkarni AR, Hukkeri VI, Sung HW, et al. A novel method for the synthesis of the PEG-crosslinked chitosan with a pH-independent swelling behavior. Macromol Biosci. 2005;5(10):925–928.
   PubMed Web of Science ®Google Scholar
• Yang L, Gao S, Asghar S, et al. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells. Int J Biol Macromol. 2015;72(10):1391–1401.
   PubMed Web of Science ®Google Scholar
• Ebrahimnejad P, Dinarvand R, Sajadi A, et al. Development and validation of an ion-pair HPLC chromatography for simultaneous determination of lactone and carboxylate forms of SN-38 in nanoparticles. J Food Drug Anal. 2009;17(4):246–256.
   Web of Science ®Google Scholar
• Sharifi F, Nazir I, Asim MH, et al. Zeta potential changing self-emulsifying drug delivery systems utilizing a novel Janus-headed surfactant: a promising strategy for enhanced mucus permeation. J Mol Liq. 2019;291(15):111285–111295.
   Web of Science ®Google Scholar
• Taleghani AS, Ebrahimnejad P, Heydarinasab A, et al. Adsorption and controlled release of iron-chelating drug from the amino-terminated PAMAM/ordered mesoporous silica hybrid materials. J Drug Delivery Sci Technol. 2020;56:101579.
   Web of Science ®Google Scholar
• Sharifi F, Jahangiri M. Investigation of the stability of vitamin D in emulsion-based delivery systems. Chem Ind Chem Eng. 2018;24(2):28.
   Web of Science ®Google Scholar
• Nazeri N, Avadi MR, Faramarzi MA, et al. Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles. Int J Biol Macromol. 2013;62:642–646.
   PubMed Web of Science ®Google Scholar
• Prego C, Torres D, Fernandez-Megia E, et al. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree. J Control Release. 2006;111(3):299–308.
   PubMed Web of Science ®Google Scholar
• Sun X, Dabu Zhu YC, Shi G, et al. One-step mechanochemical preparation and prominent antitumor activity of SN-38 self-micelle solid dispersion. Int J Nanomed.. 2019;14(14):2115–2126.
   PubMed Web of Science ®Google Scholar
• Gu Q, Xing JZ, Huang M, et al. SN-38 loaded polymeric micelles to enhance cancer therapy. Nanotechnology. 2012;23(20):205101–205115.
   PubMed Web of Science ®Google Scholar
• Varnamkhasti BS, Hosseinzadeh H, Azhdarzadeh M, et al. Protein corona hampers targeting potential of MUC1 aptamer functionalized SN-38 core-shell nanoparticles. Int J Pharm. 2015;494(1):430–444.
   PubMed Web of Science ®Google Scholar
• Wu Q-X, Lin D-Q, Yao S-J. Design of chitosan and its water soluble derivatives-based drug carriers with polyelectrolyte complexes. Mar Drugs. 2014;12(12):6236–6253.
   PubMed Web of Science ®Google Scholar
• Vangara KK, Liu JL, Palakurthi S. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Anticancer Res. 2013;33(6):2425–2434.
   PubMed Web of Science ®Google Scholar
• Kibria G, Hatakeyama H, Harashima H. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system. Arch Pharm Res. 2014;37(1):4–15.
   PubMed Web of Science ®Google Scholar
• Balimane PV, Chong S. Cell culture-based models for intestinal permeability: a critique. Drug Discov Today. 2005;10(5):335–343.
   PubMed Web of Science ®Google Scholar
• Hilgers AR, Conradi RA, Burton PS. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res. 1990;7(9):902–910.
   PubMed Web of Science ®Google Scholar
• Choi KY, Min KH, Yoon HY, et al. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials. 2011;32(7):1880–1889.
   PubMed Web of Science ®Google Scholar
• Nasirizadeh S, Jaafari MR, Iranshahi M, et al. The effect of efflux pump inhibitors on in vitro and in vivo efficacy of solid lipid nanoparticles containing SN38. J Drug Delivery Sci Technol. 2020;60:101969.
   Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–951.
   PubMed Web of Science ®Google Scholar